WallStreetZenWallStreetZen

NASDAQ: KRRO
Korro Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KRRO

Based on 8 analysts offering 12 month price targets for Korro Bio Inc

Min Forecast
$15.00+15.47%
Avg Forecast
$20.75+59.74%
Max Forecast
$30.00+130.95%

Should I buy or sell KRRO stock?

Based on 8 analysts offering ratings for Korro Bio Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KRRO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KRRO as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their KRRO stock forecasts and price targets.

KRRO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-19
lockedlocked$00.00+00.00%2026-05-18
lockedlocked$00.00+00.00%2026-03-13
lockedlocked$00.00+00.00%2026-03-13
lockedlocked$00.00+00.00%2026-02-19
Chardan Capital
Top 4%
97
Strong BuyUpgrades$15.00+15.47%2026-01-29Find out why
Piper Sandler
Top 6%
95
Strong BuyUpgrades$30.00+130.95%2026-01-29Find out why
Oppenheimer
Bottom 3%
3
BuyUpgrades$22.00+69.36%2026-01-28

1 of 1

Forecast return on equity

Is KRRO forecast to generate an efficient return?

Company
-68.53%
Industry
94.37%
Market
175.99%
KRRO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KRRO forecast to generate an efficient return on assets?

Company
-44.65%
Industry
27.62%
KRRO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KRRO earnings per share forecast

What is KRRO's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$6.08
Avg 2 year Forecast
-$5.47
Avg 3 year Forecast
-$6.09

KRRO revenue forecast

What is KRRO's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$655.7k-82.93%
Avg 2 year Forecast
$255.0k-93.36%
Avg 3 year Forecast
$0.0-100%

KRRO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRRO$12.99$20.75+59.74%Strong Buy
ADAG$3.94$10.00+153.81%Strong Buy
GALT$2.83N/AN/A
CGEN$2.01$5.00+148.76%Strong Buy
OTLK$1.58$3.83+142.59%Hold
View Top Biotech Stocks

Korro Bio Stock Forecast FAQ

Is Korro Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: KRRO) stock is to Strong Buy KRRO stock.

Out of 8 analysts, 5 (62.5%) are recommending KRRO as a Strong Buy, 3 (37.5%) are recommending KRRO as a Buy, 0 (0%) are recommending KRRO as a Hold, 0 (0%) are recommending KRRO as a Sell, and 0 (0%) are recommending KRRO as a Strong Sell.

If you're new to stock investing, here's how to buy Korro Bio stock.

What is KRRO's earnings growth forecast for 2026-2028?

(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.05%.

Korro Bio's earnings in 2026 is -$113,498,000.On average, 12 Wall Street analysts forecast KRRO's earnings for 2026 to be -$87,618,561, with the lowest KRRO earnings forecast at -$100,069,567, and the highest KRRO earnings forecast at -$52,548,637. On average, 11 Wall Street analysts forecast KRRO's earnings for 2027 to be -$78,939,058, with the lowest KRRO earnings forecast at -$100,917,614, and the highest KRRO earnings forecast at -$52,548,637.

In 2028, KRRO is forecast to generate -$87,775,767 in earnings, with the lowest earnings forecast at -$108,974,062 and the highest earnings forecast at -$46,945,469.

What is KRRO's revenue growth forecast for 2026-2028?

(NASDAQ: KRRO) Korro Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Korro Bio's revenue in 2026 is $3,842,000.On average, 12 Wall Street analysts forecast KRRO's revenue for 2026 to be $9,457,125, with the lowest KRRO revenue forecast at $0, and the highest KRRO revenue forecast at $68,146,648. On average, 10 Wall Street analysts forecast KRRO's revenue for 2027 to be $3,677,756, with the lowest KRRO revenue forecast at $0, and the highest KRRO revenue forecast at $22,715,549.

In 2028, KRRO is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is KRRO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: KRRO) forecast ROA is -44.65%, which is lower than the forecast US Biotechnology industry average of 27.62%.

What is KRRO's Price Target?

According to 8 Wall Street analysts that have issued a 1 year KRRO price target, the average KRRO price target is $20.75, with the highest KRRO stock price forecast at $30.00 and the lowest KRRO stock price forecast at $15.00.

On average, Wall Street analysts predict that Korro Bio's share price could reach $20.75 by May 19, 2027. The average Korro Bio stock price prediction forecasts a potential upside of 59.74% from the current KRRO share price of $12.99.

What is KRRO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KRRO) Korro Bio's current Earnings Per Share (EPS) is -$11.67. On average, analysts forecast that KRRO's EPS will be -$6.08 for 2026, with the lowest EPS forecast at -$6.94, and the highest EPS forecast at -$3.64. On average, analysts forecast that KRRO's EPS will be -$5.47 for 2027, with the lowest EPS forecast at -$7.00, and the highest EPS forecast at -$3.64. In 2028, KRRO's EPS is forecast to hit -$6.09 (min: -$7.56, max: -$3.26).

What is KRRO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: KRRO) forecast ROE is -68.53%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.